Exchange: NASDAQ·Updated 04:00 PM EDT

FOCL FocalTherics - ADR

$4.15
$0.22
(5.03%)
Today
EarningsNov 5
Mkt Cap$155.55M
Vol30,740.00

About FOCL

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.
50

Neutral Sentiment

How do you feel about FOCL?

WallStreetWoof
$FOCL Per AI bot... "Results from EDAP's Phase 3 study on the efficacy of HIFU in treating deep infiltrating rectal endometriosis are currently being prepared for publication, but a specific date for the release of results has not been provided. The study has already received CE Marking in Europe and FDA Breakthrough Device Designation, indicating its significance in the field."
3
WallStreetWoof
$FOCL Wow, no posts for almost 3 weeks.... guess I will postulate: How much of the DIE market can HIFU service ? rough estimates: (please do your own dd, and not rely on these..this is food for thought ) Women with endometriosis worldwide. ~190M Estimated share with deep disease ~20% or 38M IMARC estimates the overall global endometriosis market at US$2.6 billion in 2025, Att a guess 20% of 2.6B ~$500M market potential for DIE HIFU vs current opportunities? (Source from AI) * Diagnostic market: specialist ultrasound, MRI and diagnostic services. * Treatment market: hormonal therapies, pain management and follow-up care. * Surgical market: laparoscopic excision, surgical instruments and specialist multidisciplinary care for complex disease.
2
JBird17
$FOCL this company needs out of France entirely. Whole country is being destroyed in protests right now.
1
HypnoTrader
$FOCL looking at today's 13f/g filings, at least we know that about 4 million of the 8+ million they issued in the last dilution are in good hands.
HypnoTrader
$FOCL doesn't even have an FDA application for this yet. They simply cannot be involved in any treatment of patients with this proceedure at this point. Your post was deceptive.

Advertisement|Remove ads.